Product information

Vimpat 200 mg
56 (56 x 1)
lacosamide
2962116
0 / 10
Locked

Product properties

175481-36-4
N03AX18
UCB Pharma
Film-coated tablet
EU/1/08/470/023
05413787101771
M1
Public
439494-01

Pharmacist Assessment

Chronically unavailable product

This product is officially available but is structurally not or barely supplied (current score 0/10, historical score 🔒/10). Consider using a structural alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.
Note: commercialization of this product will be stopped on 31/12/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Planned
From 31/12/2026

Commercial reasons

Alternative available
Available Active
Until 30/12/2026

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
200 mg
175481-36-4

Additional information

Availability statistics

Available
0 days
3
0